Related references
Note: Only part of the references are listed.Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial
Hypolite Muhindo Mavoko et al.
LANCET GLOBAL HEALTH (2017)
Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial
Sodiomon B. Sirima et al.
LANCET INFECTIOUS DISEASES (2016)
Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study
Chanaki Amaratunga et al.
LANCET INFECTIOUS DISEASES (2016)
Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
Paul Sondo et al.
PLOS ONE (2016)
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study
Michele D. Spring et al.
LANCET INFECTIOUS DISEASES (2015)
Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker
Kyaw M. Tun et al.
LANCET INFECTIOUS DISEASES (2015)
In Vivo Selection of Plasmodium falciparum Pfcrt and Pfmdr1 Variants by Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Burkina Faso
Vito Baraka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P-falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine
Meera Venkatesan et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Directional Selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu Loci of Plasmodium falciparum in Kenyan Children Treated With ACT
Gisela Henriques et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Assessing the Cost-Benefit Effect of a Plasmodium falciparum Drug Resistance Mutation on Parasite Growth In Vitro
Gabrielle Froberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Plasmodium falciparum Drug Resistance Phenotype as Assessed by Patient Antimalarial Drug Levels and Its Association With pfmdr1 Polymorphisms
Maja Malmberg et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
The Role of Pfmdr1 and Pfcrt in Changing Chloroquine, Amodiaquine, Mefloquine and Lumefantrine Susceptibility in Western-Kenya P. falciparum Samples during 2008-2011
Fredrick L. Eyase et al.
PLOS ONE (2013)
Impact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains: study protocol for a randomized controlled clinical trial
Hypolite Muhindo Mavoko et al.
TRIALS (2013)
Prevalence of Single Nucleotide Polymorphisms in the Plasmodium falciparum Multidrug Resistance Gene (Pfmdr-1) in Korogwe District in Tanzania Before and After Introduction of Artemisinin-Based Combination Therapy
Thomas T. Thomsen et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Drug-resistant malaria: Molecular mechanisms and implications for public health
Ines Petersen et al.
FEBS LETTERS (2011)
Prolonged Selection of pfmdr1 Polymorphisms After Treatment of Falciparum Malaria With Artemether-Lumefantrine in Uganda
Frederick N. Baliraine et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Declining Responsiveness of Plasmodium falciparum Infections to Artemisinin-Based Combination Treatments on the Kenyan Coast
Steffen Borrmann et al.
PLOS ONE (2011)
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
Richard T. Eastman et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa
Gabrielle Holmgren et al.
INFECTION GENETICS AND EVOLUTION (2007)
Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda
Samuel L. Nsobya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa
Christin Sisowath et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)
Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria
G. S. Humphreys et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin
Amar Bir Singh Sidhu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic
C Dokomajilar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria
CT Happi et al.
ACTA TROPICA (2005)
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number
RN Price et al.
LANCET (2004)
Share Paper
